Biogen | BIIB - Attività





Attività Cambiamento Data
AbbVie USD 147.68B 12.57B 2026-09
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Amgen USD 96.05B 409M 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Incyte USD 7.29B 585.39M 2026-09
Merck USD 132.77B 2.97B 2026-09
Moderna USD 13.47B 2.51B 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 130.29B 1.23B 2026-09
Sanofi EUR 129.06B 1.04B 2026-06
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Teva Pharmaceutical Industries USD 40.04B 185M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
United Therapeutics USD 7.03B 186M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09